Therefore, this study aimed to evaluate the efficacy and safety of combining SGLT2 inhibitors with conventional intensive insulin therapy in hospitalised patients with T2DM who presented with severe hyperglycaemia. Here, INS is linked to type 2 diabetes mellitus.